Used as a key intermediate in pharmaceutical synthesis, particularly in the development of kinase inhibitors for cancer treatment. Its boronic acid group enables Suzuki-Miyaura cross-coupling reactions, allowing efficient construction of complex drug molecules. Commonly employed in medicinal chemistry for creating pyridine-based scaffolds with enhanced binding affinity and metabolic stability. Also utilized in the synthesis of bioactive compounds targeting inflammatory and neurodegenerative diseases.